Investors Frenzy: The Rush for Anduril Shares on Secondary Markets
Investors are eagerly seeking to invest in Anduril, a defense tech startup, even before its next funding round is finalized. Venture firms like Thrive Capital and Andreessen Horowitz are lining up to back the company at a reported $60 billion valuation, leaving others scrambling to buy shares on secondary markets at high premiums. The demand for Anduril shares is so significant that buyers are willing to pay steep premiums for access, reflecting the divide in private markets between VC firms and other investors.
The rush for Anduril shares on secondary markets is reminiscent of buying concert tickets on Stubhub when a show sells out quickly. Interested buyers have been willing to pay up to a 40% premium above the $60 billion valuation to acquire Anduril shares, which is unusually high compared to typical premiums in the 5% to 15% range. The company's cofounders have expressed concerns about unauthorized sales of its shares and have tightly controlled the stock supply to prevent fraud and maintain control over the company's ownership.
Anduril's limited supply of shares has made them among the hardest to obtain for any startup, driving investor frenzy in the secondary market. Despite the high demand for its shares, the company has not raised its share price to avoid leaving money on the table. Just like Nike doesn't sell sneakers for $2000 even if there is a secondary market for hard-to-get shoes, Anduril prefers to raise capital from its chosen VCs at a reasonable price. The company has achieved a $60 billion valuation by working with top investors and aims to continue its growth with their support.